PRGX Announces Fourth Quarter and Fiscal Year 2009 Financial Results

Share

ATLANTA, March 1, 2010 (GLOBE NEWSWIRE) -- PRGX Global, Inc. (Nasdaq: PRGX), the world's leader in recovery audit and the pioneer in a new category of services called profit discovery, today announced its unaudited financial results for the fourth quarter (Q4) and fiscal year (FY) 2009.

Highlights

Q4 2009 vs. Q4 2008

  • Revenues for Q4 2009 were $49.5 million vs. $48.6 million in Q4 2008 – an increase of 1.9% (a decline of 3.1% after adjustment for foreign exchange)
  • Net earnings for Q4 2009 were $2.0 million ($0.09 per basic share and $0.08 per diluted share) vs. $6.7 million ($0.30 per basic share and $0.29 per diluted share) in Q4 2008
  • Adjusted EBITDA for Q4 2009 was $7.0 million vs. $9.5 million in Q4 2008

FY 2009 vs. FY 2008

  • Revenues for FY 2009 were $179.6 million vs. $195.7 million in FY 2008 – a decrease of 8.2% (a decline of 4.2% after adjustment for foreign exchange)
  • Net earnings for FY 2009 were $15.3 million ($0.67 per basic share and $0.65 per diluted share) vs. $19.0 million ($0.87 per basic share and $0.83 per diluted share) in FY 2008
  • Adjusted EBITDA for FY 2009 was $27.5 million vs. $36.5 million in FY 2008

"Given the challenging economic environment and the transition that we initiated in 2009, we have delivered solid results," said Romil Bahl, president and chief executive officer. "With our second key acquisition behind us now, we feel good about how we are positioned to execute in 2010, which is the first year of implementing our new strategy." Bahl further stated, "Our 2009 results reflect the significant and ongoing investments we are making in our healthcare business, and as part of our growth strategy, we remain committed to our previously announced plans for investments in each of our service areas – Audit, Analytics and Advice."

Fourth Quarter Results

Net earnings for the 2009 fourth quarter were $2.0 million, or $0.09 per basic share and $0.08 per diluted share, compared to net earnings of $6.7 million, or $0.30 per basic share and $0.29 per diluted share for the same period in 2008. Pre-tax fourth quarter 2009 earnings included charges of $0.8 million related to stock-based compensation and $0.2 million of foreign currency losses on intercompany balances. Pre-tax fourth quarter 2008 earnings included a credit of $2.8 million for stock-based compensation and a $1.9 million charge for foreign currency losses on intercompany balances. The stock-based compensation credit in the fourth quarter of 2008 resulted from the quarterly remeasurement of the Company's liability-classified stock-based compensation awards to fair value.

Adjusted EBITDA for the 2009 fourth quarter was $7.0 million compared to $9.5 million of adjusted EBITDA for the same period in 2008. The 2009 fourth quarter adjusted EBITDA is earnings before interest, taxes, depreciation and amortization (EBITDA) excluding the $0.8 million charge related to stock-based compensation and the $0.2 million of foreign currency losses on intercompany balances. The comparable adjusted EBITDA amount for the fourth quarter of 2008 excludes from EBITDA for such period the $2.8 million credit for stock-based compensation and the $1.9 million of foreign currency losses on intercompany balances. (Schedule 3 attached to this press release provides a reconciliation of net earnings to each of EBITDA and adjusted EBITDA).

Consolidated revenue for the fourth quarter of 2009 was $49.5 million, an increase of $0.9 million, or 1.9%, compared to $48.6 million for the same period in 2008. On a constant dollar basis, adjusted for changes in foreign currency exchange rates, 2009 fourth quarter revenue declined 3.1% compared to the same period in 2008.

Fiscal Year Results

Net earnings for 2009 were $15.3 million, or $0.67 per basic share and $0.65 per diluted share, compared to net earnings of $19.0 million, or $0.87 per basic share and $0.83 per diluted share for 2008. Pre-tax 2009 earnings included charges of $3.3 million related to stock-based compensation and $0.7 million related to a previously reported litigation settlement, $1.6 million of foreign currency gains on intercompany balances and a $2.4 million bargain purchase gain on the previously reported acquisition of First Audit Partners LLP completed on July 16, 2009. Pre-tax 2008 earnings included charges of $2.2 million for stock-based compensation and $3.3 million of foreign currency losses on intercompany balances.

Adjusted EBITDA for 2009 was $27.5 million compared to $36.5 million of adjusted EBITDA for 2008. The 2009 adjusted EBITDA excludes the $3.3 million charge for stock-based compensation, the $0.7 million charge related to the litigation settlement, the $1.6 million of foreign currency gains on intercompany balances and the $2.4 million bargain purchase gain. The comparable adjusted EBITDA amount for 2008 excludes the $2.2 million stock-based compensation charge and the $3.3 million of foreign currency losses on intercompany balances.

Consolidated revenue in 2009 was $179.6 million, a decrease of $16.1 million, or 8.2%, compared to $195.7 million in 2008. On a constant dollar basis, adjusted for changes in foreign currency exchange rates, revenue in 2009 declined 4.2% compared to 2008.

Liquidity

At December 31, 2009, the Company had cash and cash equivalents of $33.0 million and had no borrowings against its revolving credit facility. Total debt outstanding at year-end was $14.3 million, which included a $14.1 million outstanding balance on a variable rate term loan due 2011 and a $0.2 million capital lease obligation. Net cash provided by operating activities for the 2009 fourth quarter was $10.5 million compared to $8.8 million in the 2008 fourth quarter. Net cash provided by operating activities for the 2009 fiscal year was $18.2 million compared to $16.7 million in 2008.

Fourth Quarter Earnings Call

As previously announced, management will hold a conference call tomorrow morning at 8:30 AM (Eastern Time) to discuss the Company's fourth quarter and fiscal year 2009 financial results. To access the conference call, listeners in the U.S. and Canada should dial 800-591-6942 at least 5 minutes prior to the start of the conference. Listeners outside the U.S. and Canada should dial 617-614-4909. To be admitted to the call, listeners should use passcode 88370448. A replay of the call will be available approximately two hours after the conclusion of the live call, extending through April 2, 2010. To directly access the replay, dial 888-286-8010 (U.S. and Canada) or 617-801-6888 (outside the U.S. and Canada). The passcode for the replay is 78730635.

This teleconference will also be audiocast on the Internet at www.prgx.com (click on "Audio Archives" under "Investors"). A replay of the audiocast will be available at the same location on www.prgx.com beginning approximately two hours after the conclusion of the live audiocast, extending through April 2, 2010. Please note that the Internet audiocast is "listen-only." Microsoft Windows Media Player is required to access the live audiocast and the replay and can be downloaded from www.microsoft.com/windows/mediaplayer.

About PRGX Global, Inc.

Headquartered in Atlanta, Georgia, PRGX Global, Inc. is pioneering "profit discovery," the combination of audit, analytics and advisory services to improve client financial performance. PRGX remains the world's leader in recovery auditing. It serves the majority of the top 50 global retailers and many other leading companies, and is active in an expanding range of markets, including healthcare. Until January 2010, PRGX was known as PRG-Schultz International, Inc.

The PRGX Global, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7003

Non-GAAP Financial Measures

EBITDA and adjusted EBITDA are both "non-GAAP financial measures" presented as supplemental measures of our performance. They are not presented in accordance with accounting principles generally accepted in the United States, or GAAP. The Company believes these measures provide additional meaningful information in evaluating the Company's performance over time, and that the rating agencies and a number of lenders use EBITDA and similar measures for similar purposes. In addition, a measure similar to adjusted EBITDA is used in the restrictive covenants contained in the Company's secured credit facility. However, EBITDA and adjusted EBITDA have limitations as analytical tools, and you should not consider them in isolation, or as substitutes for analysis of our results as reported under GAAP. In addition, in evaluating EBITDA and adjusted EBITDA, you should be aware that, as described above, the adjustments may vary from period to period and in the future we will incur expenses such as those used in calculating these measures. Our presentation of these measures should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items. Schedule 3 to this press release provides a reconciliation of net earnings to each of EBITDA and adjusted EBITDA.

Forward-Looking Statements

In addition to historical information, this press release includes certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include both implied and express statements regarding the Company's financial condition, its outlook on the economic environment and its growth strategy and possibilities for the future.Such forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from the historical results or from any results expressed or implied by such forward-looking statements. Risks that could affect the Company's future performance include revenues that do not meet expectations or justify costs incurred, the Company's ability to execute its business strategy and develop material sources of new revenue in addition to revenues from its core accounts payable services, changes in the market for the Company's services, the Company's ability to retain existing personnel, potential legislative and regulatory changes applicable to the Medicare recovery audit contractor program, uncertainty in the credit markets, client bankruptcies, loss of major clients, and other risks generally applicable to the Company's business. For a discussion of other risk factors that may impact the Company's business, please see the Company's filings with the Securities and Exchange Commission, including its Form 10-K filed on March 16, 2009. The Company disclaims any obligation or duty to update or modify these forward-looking statements.

SCHEDULE 1
PRGX Global, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
(Amounts in thousands, except per share data)
(Unaudited)
         
  Three Months Twelve Months
  Ended December 31, Ended December 31,
  2009 2008 2009 2008
         
Revenues  $ 49,539  $ 48,613  $ 179,583  $ 195,706
Cost of revenues  33,003  31,539  116,718  125,901
Gross margin  16,536  17,074  62,865  69,805
         
Selling, general and administrative expenses  12,376  8,022  43,873  44,028
         
Operating income  4,160  9,052  18,992  25,777
         
Gain on bargain purchase, net  --   --   2,388  -- 
Income before interest and taxes  4,160  9,052  21,380  25,777
         
Interest expense, net  871  700  3,025  3,245
         
Earnings before income taxes  3,289  8,352  18,355  22,532
         
Income taxes  1,261  1,630  3,028  3,502
         
Net earnings  $ 2,028  $ 6,722  $ 15,327  $ 19,030
         
         
Basic earnings per common share  $ 0.09  $ 0.30  $ 0.67  $ 0.87
         
Diluted earnings per common share  $ 0.08  $ 0.29  $ 0.65  $ 0.83
         
Weighted average common shares outstanding:        
Basic  23,450  22,137  22,915  21,829
Diluted  23,880  23,132  23,560  23,008
 
SCHEDULE 2
PRGX Global, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(Amounts in thousands)
     
     
  December 31, 2009 December 31, 2008
  (Unaudited)  
ASSETS     
Current assets:    
Cash and cash equivalents  $ 33,026  $ 26,688
Restricted cash  256  61
Receivables:    
Contract receivables  32,515  33,711
Employee advances and miscellaneous receivables  276  285
Total receivables  32,791  33,996
     
Prepaid expenses and other current assets  2,335  2,264
Total current assets  68,408  63,009
     
Property and equipment, net  10,003  7,901
Goodwill  4,600  4,600
Intangible assets, net  24,104  18,968
Other assets  3,398  4,305
 Total assets   $ 110,513  $ 98,783
     
LIABILITIES AND SHAREHOLDERS' EQUITY    
Current liabilities:    
Current portions of debt obligations  $ 3,260  $ 5,314
Accounts payable and accrued expenses  15,707  16,275
Accrued payroll and related expenses  19,884  22,536
Refund liabilities and deferred revenue  8,383  8,372
Acquisition obligations  2,695  -- 
Total current liabilities  49,929  52,497
     
Debt obligations  11,070  14,331
Noncurrent compensation obligations  978  2,849
Other long-term liabilities  7,097  6,396
Total liabilities  69,074  76,073
     
Shareholders' equity:    
Common stock  233  218
Additional paid-in capital  562,563  559,359
Accumulated deficit  (524,661)  (539,988)
Accumulated other comprehensive income  3,304  3,121
Total shareholders' equity  41,439  22,710
     
 Total liabilities and shareholders' equity   $ 110,513  $ 98,783
 
SCHEDULE 3
PRGX Global, Inc. and Subsidiaries
Reconciliation of Net Earnings to EBITDA and Adjusted EBITDA
(Amounts in thousands)
(Unaudited)
         
  Three Months Twelve Months
  Ended December 31, Ended December 31,
  2009 2008 2009 2008
Reconciliation of net earnings to EBITDA        
and to adjusted EBITDA:        
         
Net earnings  $ 2,028  $ 6,722  $ 15,327  $ 19,030
         
Adjust for:        
Income taxes  1,261  1,630  3,028  3,502
Interest expense, net  871  700  3,025  3,245
Depreciation and amortization  1,798  1,297  6,140  5,194
         
EBITDA  5,958  10,349  27,520  30,971
         
Foreign currency (gains) losses on        
intercompany balances  157  1,948  (1,595)  3,283
Litigation settlement  --   --   650  -- 
Stock-based compensation  845  (2,754)  3,345  2,207
Gain on bargain purchase, net  --   --   (2,388)  -- 
         
Adjusted EBITDA  $ 6,960  $ 9,543  $ 27,532  $ 36,461

EBITDA and adjusted EBITDA are both "non-GAAP financial measures" presented as supplemental measures of our performance. They are not presented in accordance with accounting principles generally accepted in the United States, or GAAP. The Company believes these measures provide additional meaningful information in evaluating the Company's performance over time, and that the rating agencies and a number of lenders use EBITDA and similar measures for similar purposes. In addition, a measure similar to adjusted EBITDA is used in the restrictive covenants contained in the Company's secured credit facility. However, EBITDA and adjusted EBITDA have limitations as analytical tools, and you should not consider them in isolation, or as substitutes for analysis of our results as reported under GAAP. In addition, in evaluating EBITDA and adjusted EBITDA, you should be aware that in the future we will incur expenses such as those used in calculating these measures. Our presentation of these measures should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items.

SCHEDULE 4
PRGX Global, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Amounts in thousands)
(Unaudited)
         
  Three Months Twelve Months
  Ended December 31, Ended December 31,
  2009 2008 2009 2008
Cash flows from operating activities:        
         
Net earnings  $ 2,028  $ 6,722  $ 15,327  $ 19,030
Adjustments to reconcile net earnings to net cash provided        
 by operating activities:        
Gain on bargain purchase  --   --   (2,388)  -- 
Depreciation and amortization  1,798  1,297  6,140  5,194
Amortization of debt discounts and deferred costs  198  198  789  786
Stock-based compensation expense  845  (2,754)  3,345  2,207
(Increase) decrease in receivables  (345)  (2,936)  2,558  1,578
(Decrease) increase in accounts payable, accrued        
 payroll and other accrued expenses  5,882  4,607  (5,856)  (8,796)
Other, primarily changes in assets and liabilities  120  1,626  (1,749)  (3,309)
 Net cash provided by operating activities  10,526  8,760  18,166  16,690
         
Cash flows used in investing activities:        
Business acquisition  --   --   (2,029)  -- 
Purchases of property and equipment, net of disposals  (3,446)  (1,087)  (5,511)  (3,298)
Net cash used in investing activities  (3,446)  (1,087)  (7,540)  (3,298)
         
Net cash used in financing activities  (1,448)  (3,010)  (5,701)  (28,025)
         
Effect of exchange rates on cash and cash equivalents  65  (763)  1,413  (1,043)
         
 Net increase (decrease) in cash and cash equivalents  5,697  3,900  6,338  (15,676)
         
Cash and cash equivalents at beginning of period  27,329  22,788  26,688  42,364
         
Cash and cash equivalents at end of period  $ 33,026  $ 26,688  $ 33,026  $ 26,688
CONTACT: PRGX Global, Inc. Robert Lee 770-779-6464

PRGX Global, Inc. Logo


 
 
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust

Special Offers:
Quick Cash Advance